Introduction
The conversion of carcinogen-induced DNA damage into oncogenic mutations is a major event in tumor initiation. Carcinogen-induced DNA damage causes cells to enter into a period of replication block (Slaga et al., 1973 (Slaga et al., , 1974 and repair induction (Sawyer et al., 1988; Gill et al., 1991) before continuing with the cell cycle (Kaufmann, 1995; Maher and McCormick, 1987) . Oncogenic mutations may arise from errors committed during pre-replication repair (Chakravarti et al., 1998b (Chakravarti et al., , 2000 and, also, during subsequent replication in cells harboring unrepaired DNA lesions (Maher and McCormick, 1987; Kaufmann, 1995; Moriya et al., 1996) .
Polycyclic aromatic hydrocarbons (PAH) react mainly with the purine bases of DNA to form stable and depurinating DNA adduct damage. When adducts are formed through the exocyclic amines of a purine (N 2 of Gua and N 6 of Ade), stable adducts are formed, whereas when the N3 of Ade or N7 of Ade and Gua are the reactive sites, depurinating adducts are formed . These types of DNA damage require the induction of both nucleotide excision repair (NER) and base excision repair (BER) (Braithwaite et al., 1998) . The depurinating adducts correlate with oncogenic mutations found in the H-ras gene of papillomas, suggesting that abasic (AP) sites generated by depurinating adducts are involved in the mutations that lead to tumor initiation (Chakravarti et al., 1995; Cavalieri and Rogan, 1998) .
More recently, we found that in early preneoplastic mouse skin, AP sites formed by the PAH carcinogen dibenzo [a,l] pyrene (DB[a,l]P) undergo error-prone repair to form tumor-initiating H-ras mutations. When SENCAR mouse skin is treated with DB[a,l]P, 99% depurinating adducts are formed in skin DNA . AP sites generated by these depurinating adducts induce pre-replication repair that is error-prone and forms mismatched heteroduplexes leading to transforming mutations in the H-ras gene at codon 61 (CAA to CTA) (Chakravarti et al., 1998b (Chakravarti et al., , 2000 . In contrast, a metabolite of DB[a,l]P, (+)-anti-DB[a,l]P-11,12-diol-13,14-epoxide (anti-DB[a,l]PDE), which forms 97% stable adducts in mouse skin , does not appear to induce mismatched heteroduplexes in these early preneoplastic stages (Chakravarti et al., 2000) . PAH-induced stably adducted DNA is thought to undergo error-free NER (Watanabe et al., 1985; Choi et al., 1996) .
Each cell undergoes an estimated 10 000 ± 20 000 spontaneous base losses per day (Lindahl and Nyberg, 1972; Lindahl and Karlstrom, 1973; Lindahl, 1993 , Nakamura et al., 1998 . The actual levels of AP sites in cells, however, appear to be higher (18 000 ± 200 000 AP sites per cell per day, depending on the tissue and age) (Nakamura and Swenberg, 1999; Atamna et al., 2000) . Thus, there could be tissue heterogeneity of BER. Nonetheless, BER is thought to be involved in the maintenance of the low (normal) levels of somatic mutations. It is, therefore, argued that BER of these spontaneous levels of abasic sites occurs with high ®delity (Lindahl, 2000) . Our results suggest that within 4 h of treating mouse skin with 200 nmol of DB[a,l]P, a bolus of approximately 200 000 depurinations/cell is formed . Repair produced error-induced mismatched heteroduplexes within 24 h after treatment with DB[a,l]P (Chakravarti et al., 2000) . We, therefore, hypothesize that in mouse skin, abundant depurination is a factor that aects the ®delity of abasic site repair.
Evidence that depurinating PAH-DNA adducts play a major role in tumor initiation (Chakravarti et al., 1995) lends support to the idea that estrone-3,4-quinone (E 1 -3,4-Q) and estradiol-3,4-quinone (E 2 -3,4-Q), which form depurinating DNA adducts, can be potential endogenous initiators of breast and other human cancers (Cavalieri et al., 1997; Stack et al., 1998) , but they do not induce tumors in mouse skin (Cavalieri and Rogan, unpublished observations) . Reaction of DNA with E 2 -3,4-Q generates 499% depurinating adducts and 51% stable adducts (Cavalieri et al., 1997) . The depurinating adducts consist of 4-hydroxyestradiol (4-OHE 2 )-1-N7Gua and 4-OHE 2 -1-N3Ade adducts (Cavalieri et al., 1997; Stack et al., 1998; Li et al., 1998) . The 4-OHE 2 -1-N3Ade adducts depurinate instantaneously, whereas the 4-OHE 2 -1-N7Gua adducts depurinate more slowly (t 1/2 =5 h) (Li et al., 1999) .
The dierences in stability of E 2 -3,4-Q-induced depurinating adducts provides a way to examine the eect of abundant depurination in mouse skin DNA on repair ®delity. Brie¯y, E 2 -3,4-Q would challenge the mouse skin repair machinery with a burst of Adespeci®c depurinations and a slower release of Guaspeci®c depurinations. Should a burst of depurination be a contributing factor in causing repair to be errorprone, we expect a greater frequency of Ade-speci®c mutations compared to Gua-speci®c mutations in preneoplastic skin DNA. This article reports an investigation of mutagenesis by E 2 -3,4-Q in the mouse skin H-ras gene.
Results and discussion
E 2 -3,4-Q induces primarily depurinating DNA adducts in mouse skin
Previous studies indicate that E 2 -3,4-Q reacts in vitro and in rat mammary gland with DNA to form primarily two depurinating adducts, 4-OHE 2 -1-N3Ade and 4-OHE 2 -1-N7Gua (Figure 1 ), as well as trace amounts of stable adducts (Dwivedy et al., 1992; Cavalieri et al., 1997; Li et al., 1998; Jankowiak et al., 1998b) . We conducted two independent experiments (one with seven mice and the other with six mice) in which the animals were treated on the dorsal skin with 200 nmol of E 2 -3,4-Q and sacri®ced 1 h later for isolation of epidermis from the treated area of skin. The 1 h time point was found to be optimal for the determination of DNA adducts formed by E 2 -3,4-Q. Depurinating adducts formed by E 2 -3,4-Q were determined after they were extracted from mouse skin, whereas the stable adducts were determined in DNA puri®ed from the pooled epidermis.
Depurinating adducts were identi®ed and quanti®ed by high performance liquid chromatography (HPLC) with electrochemical detection and veri®ed by liquid chromatography/tandem mass spectrometry, as described before (Cavalieri et al., 1997) . The retention times with capillary HPLC and the product-ion spectra of the synthetic standards were nearly identical to those of the modi®ed nucleobases isolated from the mouse skin samples. The spectral quality was good: both spectra had a signal to noise ratio of 50 : 1 for the most intense peak. The product-ion spectra of the 4-OHE 2 -1-N7Gua standard and unknown showed ions at m/z 420, 312, 298, 286 and 272. The latter four of these fragment ions are generated by charge-remote, cross-ring cleavages, making them highly characteristic of a structure containing the estrogen ring system. The 4-OHE 2 -1-N3Ade adduct was also identi®ed: both the standard and unknown aorded fragment ions of m/z 404, 393, 375, 347, 281, 256 and 229. The ions of m/z 281 and 256 are also produced from cross-ring fragmentations, which are highly characteristic for a structure with attachment of the steroid moiety to a nucleobase, whereas the higher mass fragments are produced by losses of ammonia, water, and part of the purine ring of Ade.
Stable adducts that were formed from E 2 -3,4-Q were examined in epidermal DNA by using 32 P-postlabeling (Dwivedy et al., 1992) . Treatment of mouse skin with 200 nmol E 2 -3,4-Q for 1 h resulted in trace levels of stable adducts and approximately 25 mmol depurinating adducts/mol DNA-phosphate. This level is similar to the level of depurinating adducts formed by reaction of 200 nmol DB[a,l]P (20 mmol/mol DNA-phosphate) in mouse skin . Approximately equal amounts of 4-OHE 2 -1-N7Gua and 4-OHE 2 -1-N3Ade depurinating adducts were observed ( Table 1 ). The N3Ade adduct depurinates rapidly from DNA, whereas the N7Gua adduct depurinates more slowly, with a half-life of 5 h (Li et al., 1999) . We used a 24 h-long Soxhlet extraction of epidermal tissue samples and this causes complete depurination, abrogating the possibility of observing any dierences in yield of the two depurinating adducts corresponding to their dierent stabilities in DNA. In mouse skin, however, relatively more N3Ade adducts than N7Gua adducts would undergo depurination in the early preneoplastic period.
PCR artifact mutations in undamaged and estrogendamaged H-ras gene
An 8 : 1 combination of Tth and Vent DNA polymerase for PCR ampli®cation allows superior proofreading and results in low rates of spontaneous artifact errors (Chakravarti et al., 1998a,b) . To determine the frequency and type of PCR-induced spontaneous artifact mutations, we ampli®ed a 500 bp-long sequence from the exon 1 ± 2 region of the H-ras gene from untreated SENCAR mouse skin DNA (Figure 2 ). The PCR product was cloned in pUC18 and transfected into Escherichia coli One-shot INVaF' cells. Individual subclones were isolated and the H-ras inserts in the plasmids sequenced. One mutation (A 228 to G) among 36 plasmids (mutation frequency=5.5610 75 ) was observed. This result compares well with that from our previous determination of the frequency of spontaneous artifact mutations by 8 : 1 Tth and Vent DNA polymerase in the H-ras gene ( 6610 75 ) (Chakravarti et al., 2000) . E 2 -3,4-Q treatment of mouse skin produced both depurinating (499%) and stable (51%) DNA adducts ( Table 1 ) that would induce excision repair. It is possible that some stable adducts and AP sites formed by depurination of unstable adducts would remain unrepaired and become sites where PCR would make adduct-induced artifact mutations. The results from a DNA polymerase bypass analysis reported in the literature indicate that 2-OHE 2 -induced stable adducts are mutagenic (Terashima et al., 2001) . In this study, 2-OHE 2 -N 6 dA adducts caused mostly A to T and some A to G mutations, whereas 2=OHE 2 -N 2 dG adducts induced mainly G to T mutations. To understand the nature of estrogeninduced PCR artifact mutations in the H-ras gene, we treated 2 mg of the plasmid pWT (containing a 500 bp-long H-ras (exon 1 ± 2 region) insert in pBluescriptII KS7) either with 200 nmol of E 2 -3,4-Q or with 600 nmol of E 2 -2,3-Q, as described previously (Chakravarti et al., 1998a) . The treated plasmid samples were PCR ampli®ed, cloned in pUC18, transformed into E. coli and the H-ras inserts sequenced from individual subclones (Figure 2 ). The data are an average of the results obtained from two experiments. The levels of depurinating adducts varied by 410%, and the levels of stable adducts varied by 30%. As a positive control for the 32 P-postlabeling analysis, 1.25 mg of calf-thymus DNA was reacted with 3.5 mmol of E 2 -2,3-Q, which formed 1.78 mmol stable adducts/mol DNA-P. No mutations were found in thirty-two E 2 -3,4-Qtreated plasmids. The treatment would form abasic sites (estimated frequency=1 AP site/1000 bp) (Cavalieri et al., 1997) . In a previous experiment, we found that abasic sites generated by acid-induced depurination in pWT also did not result in PCR-induced artifacts (Chakravarti et al., 2000) . Previous results by Fromenty et al. (2000) and us (Chakravarti et al., 2000) indicate that abasic sites render DNA refractory to PCR ampli®cation.
On the other hand, we scored four mutations (two A/T to G/C and two G/C to A/T) in 35 E 2 -2,3-Qtreated plasmids. This corresponds to a frequency of 2.3610 74 mutations. Presumably, these mutations are induced from 2-OHE 2 -N 6 dA and 2-OHE 2 -N 2 dG stable adducts (Terashima et al., 2001 ). E 2 -3,4-Q induces primarily A/T to G/C mutations in the mouse skin H-ras gene Eight-week-old female SENCAR mice were treated on the dorsal skin with 200 nmol E 2 -3,4-Q. The mice were sacri®ced 6 h, 12 h, 1 day and 3 days after the treatment and treated (dorsal) and untreated (belly) areas of skin were harvested for analysis. As described in Table 1 , this treatment generates 25 mmol depurinating adducts/mol DNA-phosphate in epidermal DNA. A 500 bp-long H-ras exon 1 ± 2 segment was PCR ampli®ed from chromosomal DNA of the treated (dorsal) skin samples and cloned in pUC18, transformed in E. coli and the H-ras inserts in the clones sequenced to determine mutations (Chakravarti et al., 2000) . Six hours after treatment, seven mutations were identi®ed among 29 plasmids (Figure 3 ). Five out of the seven mutations were A/T to G/C transitions. At 12 h, six mutations were identi®ed from 30 plasmids, of which four were A/T to G/C transitions. At 1 day, 11 mutations were identi®ed from 50 plasmids, of which seven were A/T to G/C transitions. At 3 days, four mutations were identi®ed from 40 plasmids, three of which were A to G mutations and the fourth was an A to T mutation.
It would be of considerable interest to determine what fraction of DNA damage becomes converted into mutations in vivo. Our results suggest that E 2 -3,4-Q induces a higher frequency of mutations in the H-ras gene (2.2610 74 between 6 ± 12 h) than that expected from averaging the extent of DNA damage (2.5610 75 ) ( Table 1 ). We previously observed that DB[a,l]P treatment of SENCAR mouse skin also induced a similarly higher frequency of H-ras mutations than the average damage in epidermal DNA (Chakravarti et al., 2000) . Other articles also report similarly high mutation frequencies in transgenic reporter genes in mouse skin. For example, 400 nmol of 7,12-dimethylbenz[a]anthracene (DMBA) applied to BigBlue mouse skin induced 3610 74 mutations in the lacI gene (Gorelick et al., 1995) and 100 nmol of benzo[a]pyrene (BP) applied to MutaMouse skin induced 5 ± 7610 74 mutations in the lacZ gene (Dean et al., 1998) . There appear to be gene-gene dierences in the frequency of mutagenesis. For example, BP treatment of mice was found to induce 40-fold fewer mutations in the endogenous hprt gene than in the transgenic lacI gene in spleen T cells (Skopek, et al., 1996) .
Such gene-gene dierences in mutagenesis may be related to clustered adduct formation in the chromosome. Clustered adduct formation has been noted by electron microscopic (Paules et al., 1988) and¯uores-cence spectroscopic (Jankowiak et al., 1998a) studies. The data from the¯uorescence study suggest that once formed, a bulky DNA adduct may induce cooperative in¯uences on neighboring bases to form additional adducts (Jankowiak et al., 1998a) . Furthermore, the extent of adduct formation may depend on the cell cycle. For example, one study reported that DMBA treatment resulted in 50% more adducts in resting cells than in proliferating cells . In At indicated times after treatment, groups of mice were sacri®ced, skin harvested, genomic DNA extracted, the H-ras gene (exon 1 ± 2 region) PCR ampli®ed and cloned in pUC18. Individual clones were isolated and sequenced to determine mutation spectra. Note that the mutations mainly consisted of A/T to G/C transitions addition, chemical quanti®cation of depurinating adducts underestimates the true level of these adducts due to losses during the HPLC analyses (Rogan et al., 1993, Chakravarti et al., unpublished results) . Such observations indicate that the in vivo frequency of mutagenesis from adducted chromosomal DNA would be dicult to determine. As described above, of the two depurinating adducts formed by E 2 -3,4-Q, the 4-OHE 2 -1-N7Gua adduct depurinates more slowly (t 1/2 =5 h), whereas the 4-OHE 2 -1-N3Ade adduct depurinates instantaneously (Li et al., 1998) . The abundance of E 2 -3,4-Q-induced A/T to G/C mutations in the H-ras gene, therefore, correlates with the burst of depurination caused by N3Ade adducts, rather than with the slower depurination of N7Gua adducts.
Early A to G mutations were G.T heteroduplexes PAH treatment leads to the induction of DNA damage repair that is thought to last for a relatively short period of time (Maher and McCormick, 1987) . For example, BP or DMBA treatment of skin cells induces a 24 h-long period of pre-replication repair (unscheduled DNA synthesis) (Sawyer et al., 1988; Gill et al., 1991) . Our results suggest that errors committed in this repair period may lead to transforming mutations (Chakravarti et al., 2000) . Brie¯y, within 24 h after treatment of SENCAR mouse skin with 200 nmol DB[a,l]P, DNA depurinating damage resulted in errorprone repair, forming A to G mutations (in the form of G.T heteroduplexes). The conclusion that the early A to G mutations were in the form of G.T heteroduplexes was made on the basis of a T/G-DNA glycosylase (TDG)-PCR assay (Chakravarti et al., 2000) .
In the TDG-PCR procedure, G.T heteroduplexes in skin chromosomal DNA are converted to G.AP sites by treatment with Methanobacterium thermoautotrophicum TDG (Trevigen, USA). Since AP site-containing DNA molecules are refractory to PCR ampli®cation (Chakravarti et al., 2000; Fromenty et al., 2000) , the conversion of G.T heteroduplexes (that appear as A to G mutations in the spectra) into G.AP sites by TDG makes these DNA molecules refractory to PCR ampli®cation. Under these circumstances, the PCR preferentially ampli®es the undamaged DNA molecules from a mixture of undamaged and depurinated DNA molecules. As a result, PCR ampli®cation of the H-ras gene from the TDG-treated skin DNA, followed by cloning the PCR product and isolating and determining the sequence of individual subclones, causes a speci®c, drastic reduction of A to G mutations from the mutation spectra. In addition, the preferential PCR ampli®cation arti®cially enriches low-abundance mutations that are seen in the TDG-treated mutation spectra (e.g., DB[a,l]P treatment-induced codon 61 (CAA to CTA) mutations 24 h after treatment was arti®cially enriched by TDG treatment) (Chakravarti et al., 2000) . Following the entry of skin cells into S phase, however, A to G mutations in the form of G.T heteroduplexes are converted into G.C and A.T pairs by replication. At this stage, TDG treatment does not reduce the frequency of A to G mutations in the spectrum. Thus, the speci®c reduction of A to G mutations in the mutation spectra by this TDG-PCR procedure characterizes these mutations as G.T heteroduplexes.
Cells may not have enough time to replicate and divide by 6 h, but they may undergo repair. The observation that treatment of mouse skin with E 2 -3,4-Q induced mutations at this time is, therefore, a basis to propose that these mutations were induced by errorprone repair. Because the majority of mutations observed at 6 h to 3 days were A to G transitions, we treated these DNA samples with TDG and redetermined the mutation spectra (Figure 4) to assess whether the early mutations were present in skin DNA as G.T heteroduplexes.
TDG treatment was found to change drastically the mutation spectra in the H-ras gene between 6 h and 1 day, but made no perceptible dierence in the 3 day spectrum. The abundant A to G mutations found at 6 and 12 h before TDG treatment ( Figure 3) were not observed in the TDG-treated mutation spectra ( Figure  4) . At 6 h, two mutations (G to A and T to G) were scored among 33 plasmids and at 12 h, two mutations (C to T and G to A) were observed among 41 plasmids. In addition to reducing the number of A to G mutations, TDG treatment also reduced the overall frequency of mutations at these times. To elaborate, at 6 h, without TDG treatment, seven mutations were observed in 29 plasmids (24%) and after TDG treatment, the frequency was reduced to two mutations among 33 plasmids (6%) (P=0.07, Fisher's exact test). Similarly, at 12 h, before TDG treatment, six mutations were observed among 30 plasmids (20%), and Figure 4 H-ras mutations after TDG treatment of DNA isolated from E 2 -3,4-Q-treated skin. Note that TDG treatment drastically reduces the frequency of A/T to G/C mutations in 6 and 12 h samples, but not in 1 day and 3 days samples power to detect a true dierence of 20% and 54% power to detect a true dierence of 15% in the frequency of mutations in the before TDG and after TDG groups. These results are consistent with the idea that TDG treatment speci®cally eliminated A to G mutations at these times and, therefore, indicate that these eliminated A to G mutations were present in the form of G.T heteroduplexes.
TDG treatment of 1d DNA also induced a marked dierence in the mutation spectrum. Although a major change in the absolute frequency of A to G mutations was not seen, the overall mutation frequency was increased (from 11 out of 50 plasmids (22%) to 21 out of 33 plasmids (64%) (P50.01, w 2 test)) and the TDGtreated spectrum was dominated by two clonal mutations of equal frequency. In other words, there was a relative lowering of the frequency of A to G mutations. Such changes in mutation spectrum can only occur if TDG treatment is able to eliminate some A to G mutations. These results suggest that at day 1, some of the cells in the skin have undergone replication, converting some A to G mutations from G.T heteroduplexes into G.C and A.T pairs.
One group of the clonal mutations at day 1 was at codon 16 (AAG Lys to AGG Arg ) and the other group was an intronic C to T mutation. Because it is unlikely that the intronic mutation would aect Ras activity, we speculate that the intronic mutation is allelic to a clonally expanding codon 16 mutation. In DB[a,l]P-treated skin, we observed such clonal increase of mutations to be a phenotype of transforming mutations (Chakravarti et al., 2000) . It is, therefore, possible that the codon 16 mutation is also a transforming mutation. Because the codon 16 mutation was not observable without TDG treatment (Figure 3) , there was only a low level of clonal increase of these mutations.
In contrast, TDG treatment of day 3 DNA did not make any signi®cant change from the TDG-untreated spectrum either in the frequency (four mutations in 40 plasmids (10%) vs ®ve mutations in 39 plasmids (13%), P=0.74, Fisher's exact test) or nature of the mutations (Figures 3 and 4) . This suggests that at day 3 the mutations were double-stranded, such that TDG treatment could not aect the mutation spectrum. Since A/T to G/C transitions were the majority in the entire time period (6 h ± 3 days), we conclude that E 2 -3,4-Q-induced Ade-speci®c DNA depurinating damage (N3Ade adducts) are more mutagenic than the Guaspeci®c DNA depurinating damage (N7Gua adducts). This is consistent with the idea that abasic sites formed by a burst of depurination (N3Ade), rather than those formed by a slower depurination (N7Gua), are more closely associated with the induction of error-prone repair. The absence of the clonal mutations in the day 3 spectrum is also noteworthy, as this suggests that the clonal increase in codon 16 mutations was transient.
Conclusions
E 2 -3,4-Q is an electrophilic compound that reacts with DNA. Direct application of this compound on the skin induced formation of DNA adducts in epidermis within 1 h (Table 1 ). The observation of mutations at 6 h (Figure 3 ) may be worth noting because this suggests that signi®cant levels of mutagenesis caused by error-prone repair can take place quickly.
Overwhelming evidence in the literature supports the idea that carcinogen-induced DNA adducts are central to the induction of tumor-initiating mutations. Studies with PAH indicate that both stable and depurinating adducts may be involved. As we report here, E 2 -3,4-Q induces depurination in skin DNA that leads to mutations soon after treatment, even though this quinone is not a skin carcinogen. In this regard, a possible role of DNA sequence-speci®c reaction by the carcinogen is worthy of consideration. A comparison of sequences that contain the mutations observed between 6 h ± 1 day indicates that A to G mutations frequently occurred when the Ade residue was 5' to a Gua residue ( Figure 5 ). This observation appears to be consistent with the idea that a DNA sequence-speci®c reaction (such as at oncogenic sequences) may be an important factor that determines whether or not a DNA-damaging compound will also be carcinogenic. Very recently, Kong et al. (2000) also found that E 2 -induced DNA damage may form sequence-speci®c mutations. They observed that treatment of Chinese hamster V79 cells with E 2 resulted in the induction of Figure 5 Sequence similarity among sites of E 2 -3,4-Q-induced A/T to G/C mutations in skin H-ras DNA at 6 h ± 1 day. The sequence context (left) and the mutation with nucleotide no. (right) are shown. Italicized sequences are from the bottom strand. These mutations frequently occurred in the context of a 3'-Gua predominantly T to G and T to A mutations at speci®c sequences in the hprt gene.
Two parent compounds of estrogen quinones, 4-OHE 1 and 4-OHE 2 , are mutagenic (inducing 5 ± 25610 76 oua-resistant and 3.3 ± 6.7610 76 hprt mutations, respectively, over a background of 1.2610 76 ) in Syrian hamster embryo (SHE) cells (Tsutsui et al., 2000) . Since E 2 -3,4-Q forms primarily depurinating adducts, our results suggest that error-prone BER of abasic sites formed by E 2 -3,4-Q-induced depurination is a mutagenic mechanism. Results reported here suggest that a burst of depurination is closely related to the induction of error-prone repair. Our studies, however, do not rule out a possible contributory role of catechol estrogen-induced hydroxyl radicals from quinone-semiquinone redox cycling in mutagenesis.
Literature reports suggest that the biological response to abundant abasic site formation is multifactorial and can be complex. For example, in yeast, when BER is imbalanced by an excess of abasic sites (generated by over-expression N-methylpurine-DNA glycosylases, MPG), the rate of spontaneous mutation is increased signi®cantly (Chakravarti et al., 1991; Berdal et al., 1998; Glassner et al., 1998; Lau et al., 2000) . Chinese hamster ovary cells over-expressing human MPG (a broad spectrum glycosylase), however, when exposed to methylating agents, did not show increased mutagenesis but showed inhibition of DNA synthesis, chromosomal aberrations and DNA breaks (Ibeanu et al., 1992; Coquerelle et al., 1995) . On the other hand, Chinese hamster V79 cells over-expressing bacterial tag gene (removes only 3-methyladenine) were more resistant to cytotoxic and mutagenic eects of methylating agents (Klugland et al., 1992) . A recent study reports that the cytotoxic eects of bleomycinand g-irradiation-induced abasic sites can be signi®-cantly mitigated by over-expressing AP endonuclease in human cells (Robertson et al., 2001) .
We are presently analysing the BER ®delity of cellfree extracts on oligonucleotides containing abasic sites adjacent to the sequences that appear to be associated with A to G misrepair in mouse skin H-ras gene. These studies may provide us with more detailed understanding of the mechanism of repair error induction.
Materials and methods

Chemicals
E 2 -3,4-Q and E 2 -2,3-Q were synthesized by oxidation of 4-hydroxyestradiol (4-OHE 2 ) and 2-hydroxyestradiol (2-OHE 2 ) respectively, with activated MnO 2 as described previously (Dwivedy et al., 1992) . Caution: Estradiol quinones are toxic and suspected human carcinogens, requiring handling according to NIH guidelines (NIH, 1981) .
Analysis of E 2 -3,4-Q-DNA adducts in skin epidermis
The dorsal skins of 8-week-old female SENCAR mice (NCI, Frederick, MD, USA) were shaved and 1 day later treated with 200 nmol of freshly prepared E 2 -3,4-Q in 50 ml of 9 : 1 solution of acetone : DMSO. One hour after treatment, the mice were sacri®ced, the treated area of dorsal skin was harvested and the epidermis was separated, minced and ®nely ground in liquid N 2 (Chen et al., 1996) . Approximately 10% of the ground epidermis was used for analysing chromosomebound stable DNA adducts, and the rest of the epidermis was used for analysing depurinating DNA adducts.
The formation of stable adducts was analysed from epidermal chromosomal DNA by 32 P-postlabeling as described (Chen et al., 1996) . As a positive control for the experiment, 3.5 mmol of freshly prepared E 2 -2,3-Q was reacted with 1.25 mg of calf thymus DNA (Dwivedy et al., 1992) . Depurinating adducts were extracted from ground epidermis by Soxhlet-extraction (24 h) with chloroform/ methanol (1 : 1) (Dwivedy et al., 1992) . The solvent was removed under vacuum and the residue dissolved in 1.5 ml methanol. Depurinating adducts were initially puri®ed from the extracts by preparative HPLC using a 206250 mm YMC ODS-AQ 5 mm, 120 A Ê column and a 50-min gradient (CV-7) from 30% methanol in water to 100% methanol at a¯ow rate of 6 ml/min. Adduct-speci®c peaks were collected blind on the basis of retention times that were pre-determined with synthetic depurinating`standard' adducts (4-OHE 2 -1-N3Ade and 4-OHE 2 -1-N7Gua, 45 and 51 min, respectively). The collected fractions were evaporated, the residues were redissolved in 0.5 ± 1.0 ml of methanol/DMSO (1 : 1), and the depurinating adducts were identi®ed and quanti®ed by analytical HPLC at a¯ow rate of 0.5 ml/min through a Supelco ABZ-ODS 5-mm (4.66250 mm), 120 A Ê column, using isocratic acetonitrile (30%) in 36 mM NH 4 H 2 PO 4 (pH 3.0) as solvent with a Coulochem II electrochemical detector (ESA, Chemsford, MA, USA). The remainder of the samples was analysed by mass spectrometry.
Mass spectrometric analyses were conducted to con®rm the presence of 4-OHE 2 -1-N7Gua and 4-OHE 2 -1-N3Ade adducts by using capillary reverse-phase HPLC coupled with electrospray ionization (ESI) mass spectrometry. An aliquot of 5 ml (approximately 0.5% of the total sample) was loaded onto a C18 column (10 cm60.32 mm I.D., ZC-10-C18SBW, Sunnyvale, CA, USA) ®tted with a 0.3 mm610 mm guard column of the same packing material. The HPLC separation was performed on a Waters 600 MS system using a linear gradient acetonitrile (10 ± 70% in 35 min) in aqueous 1% acetic acid. The solvent¯ow (0.38 ml/min) from the HPLC pump was split to 4.0 ml/min with an LC Packing-Accurate Splitter (LC Packing, San Francisco, CA, USA) and introduced into a Finnigan LCQ ion-trap mass spectrometer (Finnigan MAT, San Jose, CA, USA). The ESI needle was held at 4.0 kV. Helium was used as the collision gas for the ESI tandem mass spectrometry experiments, and the collision energy was set at 40% of the maximum`tickling' voltage (5 eV). The adduct was considered to be present in the reaction mixture if the retention time of the respective adducts and the product-ion spectra were nearly those of the standards, as discussed in Results and discussion.
Determination of mutation spectra
To determine mutation spectra, 12 mice were treated on a shaved area of dorsal skin with 200 nmol E 2 -3,4-Q in 100 ml of a 70 : 30 mixture of acetone and ethanol. Three additional mice were taken as untreated controls. Three treated mice were sacri®ced at indicated intervals (6 h, 12 h, 1 day and 3 days), and the dorsal skin excised and stored at ± 808C until use. An area of untreated belly skin was excised from each mouse as control. Other methods for the determination of mutation spectra in the H-ras gene have been described previously (Chakravarti et al., 1998b (Chakravarti et al., , 2000 .
